Marsico Capital Management’s Elevance Health ELV Stock Holding History

Marsico Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-141,114	Closed	-$37.1M	–	88
2018 Q4	$37.1M	Sell	141,114 -51,013	-27%	-$14M	1.56%	19
2018 Q3	$52.7M	Sell	192,127 -3,100	-2%	-$805K	1.78%	15
2018 Q2	$46.5M	Hold	195,227	–	–	1.67%	20
2018 Q1	$42.9M	Sell	195,227 -55,626	-22%	-$13.1M	1.61%	21
2017 Q4	$56.4M	Buy	250,853 +47,864	+24%	+$10.2M	2.25%	16
2017 Q3	$38.5M	Sell	202,989 -1,109	-0.5%	-$211K	1.55%	21
2017 Q2	$38.4M	Buy	204,098 +7,020	+4%	+$1.26M	1.61%	19
2017 Q1	$32.6M	Buy	+197,078	New	+$31.3M	1.41%	22

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marsico Capital Management's ELV Position: Q1 2019 in Review

Marsico Capital Management sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 141,114 shares — an estimated $37.1M sold.

Marsico Capital Management first reported a position in ELV in Q1 2017 and held it in 8 quarters. The position peaked at $56.4M in Q4 2017. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

Marsico Capital Management reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
Marsico Capital Management sold 141,114 Elevance Health shares in Q1 2019, an estimated $37.1M.
Marsico Capital Management first reported a position in Elevance Health in Q1 2017 and held it in 8 quarters.
Marsico Capital Management's Elevance Health position peaked at $56.4M in Q4 2017.
1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Marsico Capital Management's 13F filing for Q1 2019, filed 15 May 2019.